Kazazian Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,140
Closed -$268K 60
2024
Q4
$268K Buy
+1,140
New +$268K 0.21% 39